Oribel Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Oribel Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-114,200	Closed	-$9.99M	–	207
2021 Q3	$9.99M	Buy	114,200 +7,206	+7%	+$652K	0.42%	61
2021 Q2	$9.57M	Buy	+106,994	New	+$9.04M	0.56%	43
2021 Q1	–	Sell	-110,200	Closed	-$7.51M	–	200
2020 Q4	$7.51M	Buy	+110,200	New	+$6.87M	0.97%	30

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Oribel Capital Management's SYNH Position: Q4 2021 in Review

Oribel Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 114,200 shares — an estimated $9.99M sold.

Oribel Capital Management first reported a position in SYNH in Q4 2020 and held it in 3 quarters. The position peaked at $9.99M in Q3 2021. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

Oribel Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
Oribel Capital Management sold 114,200 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $9.99M.
Oribel Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 3 quarters.
Oribel Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $9.99M in Q3 2021.
378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Oribel Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.